SUVRETTA CAPITAL MANAGEMENT, LLC 4

What Happened

• Suvretta Capital Management, LLC (reported as a 10% owner) made a series of purchases in Veradermics, Inc. (MANE) across Feb 4–6, 2026.
• The filers report acquiring a total of 282,674 shares at prices ranging from $34.25 to $39.80, for aggregate consideration of approximately $10.54 million. Individual trades include multiple lots (examples: 53,344 shares @ $37.11 = $1,979,596; 38,771 shares @ $37.63 = $1,458,953; 25,908 shares @ $38.09 = $986,836).
• These were purchases (transaction code P), which are generally a buying/accumulation signal rather than a disposition.

Key Details

• Transaction dates: Feb 4, 2026; Feb 5, 2026; Feb 6, 2026. Price range: $34.25–$39.80. Total shares: 282,674. Total spent: ≈ $10,542,477.
• Transaction type: P = Purchase (open market or private purchase as reported).
• Shares owned after transaction: Not specified in the data you provided — check the full Form 4 for post-transaction beneficial ownership amounts.
• Footnotes: Multiple footnotes reference Exhibit 99.1 for explanations; Exhibit 99.2 contains joint filer information and Exhibit 99.3 contains joint filers' signatures.
• Filing timing: Form filed on Feb 9, 2026 for trades dated Feb 4–6. Section 16 filers typically must report within two business days; this filing date appears later than that window — check the full filing for any explanation (Exhibit 99.1).

Context

• This filing reports activity by a 10% institutional owner, not a company executive — institutional buys are informative but do not reveal insider views on operations.
• All reported transactions were purchases (not exercises, awards, gifts, or sales). For retail investors, repeated purchases by a major holder can indicate accumulation, but it’s one data point among many; review company fundamentals and broader insider activity before drawing conclusions.